IDBB Tablet is a combination pharmaceutical formulation containing Pancreatin (192 mg), Bile constituents (25 mg), and Simethicone (40 mg), designed to aid in the management of digestive disorders. Pancreatin is a mixture of digestive enzymes including amylase, lipase, and protease, which facilitate the breakdown of carbohydrates, fats, and proteins, thereby improving nutrient absorption in patients with pancreatic insufficiency or other malabsorption syndromes. The inclusion of bile constituents supports the emulsification and digestion of dietary fats, enhancing lipid absorption and promoting overall digestive efficiency. Simethicone acts as an anti-foaming agent, reducing bloating and discomfort by facilitating the coalescence and expulsion of gas from the gastrointestinal tract. IDBB Tablet is indicated for conditions such as chronic pancreatitis, cystic fibrosis, post-pancreatectomy enzyme replacement, and functional dyspepsia associated with gas-related symptoms. It is generally well-tolerated, with minimal adverse effects, but should be used under medical supervision, especially in patients with allergies to porcine-derived enzymes or bile salts. The combination therapy provided by IDBB Tablet offers a comprehensive approach to improving digestion and alleviating gastrointestinal discomfort related to enzyme deficiency and gas accumulation.